Suven Life Sciences - Quaterly Results

02 Feb 2023 Evaluate
A decrease of about -32.28% in the sales to Rs. 30.02 millions was observed for the quarter ended December 2022. The sales stood at Rs. 44.33 millions during the similar quarter previous year.The Net Loss for the quarter ended December 2022 is Rs. -66.33 millions as compared to Net Loss of Rs. -82.19 millions of corresponding quarter ended December 2021 Operating profit Margin for the quarter ended December 2022 improved to -48.98% as compared to -68.67% of corresponding quarter ended December 2021


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 30.02 44.33 -32.28 109.28 76.23 43.36 118.44 134.78 -12.12
Other Income 22.05 1.41 1463.83 28.47 14.84 91.85 53.17 77.54 -31.43
PBIDT -48.98 -68.67 -28.67 -187.72 -276.87 -32.20 -313.26 -227.93 37.44
Interest 0.64 1.30 -50.77 2.35 4.33 -45.73 5.30 8.15 -34.97
PBDT -49.62 -69.97 -29.08 -130.07 -244.04 -46.70 -318.56 -236.08 34.94
Depreciation 16.71 12.22 36.74 48.72 32.90 48.09 43.93 43.46 1.08
PBT -66.33 -82.19 -19.30 -178.79 -276.94 -35.44 -362.49 -279.54 29.67
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -53.23 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -53.23 0.00
PAT -66.33 -82.19 -19.30 -178.79 -276.94 -35.44 -362.49 -226.31 60.17
Equity 218.07 127.28 71.33 218.07 127.28 71.33 145.38 127.28 14.22
PBIDTM(%) -163.16 -154.91 5.33 -171.78 -363.20 -52.70 -264.49 -169.11 56.40

Suven Life Sciences Share Price

126.30 -0.65 (-0.51%)
17-Apr-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1751.05
Dr. Reddys Lab 1163.70
Cipla 1515.45
Lupin 1936.75
Zydus Lifesciences 831.40
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
×
Please wait your portfolio is updating...